MARKET

GRMLW

GRMLW

Greenland Mines Ltd
NASDAQ
0.1492
+0.0292
+24.33%
Closed 14:01 07/31 EDT
OPEN
0.1408
PREV CLOSE
0.1200
HIGH
0.1600
LOW
0.1408
VOLUME
594
TURNOVER
--
52 WEEK HIGH
0.3800
52 WEEK LOW
0.0630
MARKET CAP
--
P/E (TTM)
-0.4448
1D
5D
1M
3M
1Y
5Y
1D
Greenland Mines launches expanded 2026 field program at Skaergaard project
PUBT · 7h ago
Greenland Mines biotech unit wins Canada patent for Klotho gene therapy platform targeting Alzheimer’s, aging
PUBT · 3d ago
BIOTECH DIVISION OF GREENLAND MINES ANNOUNCES ISSUANCE OF PATENT IN CANADA FOR THE KLOTHO GENE THERAPY PLATFORM TECHNOLOGY FOR ALZHEIMER’S AND AGING
Reuters · 3d ago
Weekly Report: what happened at GRMLW last week (0720-0724)?
Weekly Report · 4d ago
Greenland Mines director Jason Sawyer reports purchase of 240,000 common shares for $55,944
PUBT · 07/23 13:34
Greenland Mines issues shareholder rights dividend under 1-year rights plan
PUBT · 07/23 13:01
GREENLAND MINES ANNOUNCES LIMITED-DURATION STOCKHOLDER RIGHTS PLAN INTENDED TO PROTECT SHAREHOLDER VALUE
Reuters · 07/23 13:00
Greenland Mines adjournment proposal won shareholder approval at special meeting
PUBT · 07/21 20:35
More
About GRMLW
ANEW Medical, Inc. is a specialty pharmaceutical company. The Company specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The Company focuses on central nervous systems (CNS) diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease (AD), dementia symptoms and neuromuscular diseases. The Company has exclusive worldwide rights to develop and commercialize product platforms based on its proprietary isoform transcribed from the human Klotho gene referred to as secreted Klotho or s-KL. This s-KL protein or gene therapy has been recognized for its potential to mitigate age-related pathologies such as ALS, Alzheimer's and Parkinson's Disease. Its lead gene therapy product candidates are AMI-101 (AAV9-CMV-sKL) for the treatment or prevention of Alzheimer’s disease, and AMI-202 (AAVmyo-Des-sKL) gene therapy product for treatment and prevention of Lou Gehrig’s disease.

Webull offers ANEW Medical Inc stock information, including NASDAQ: GRMLW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRMLW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRMLW stock methods without spending real money on the virtual paper trading platform.